The Omega-3 Index measures the percentage of EPA and DHA in red blood cell membranes and serves as a long-term marker of omega-3 status. Observational studies link a higher index to improved insulin sensitivity and lower fasting blood glucose. Mechanistically, omega-3s reduce inflammation and enhance cell membrane fluidity, which may facilitate insulin signaling. However, randomized controlled trials show mixed results: supplementation can modestly lower blood sugar in individuals with metabolic syndrome or type 2 diabetes, but effects are minimal in healthy populations. The Omega-3 Index is not a direct blood sugar regulator but a risk indicator. Evidence is moderate, relying on epidemiological and mechanistic data. Clinically meaningful improvements are most likely in those with a low baseline index. Caveat: high doses (>3 g/day) may increase bleeding risk. The test is lifestyle-oriented, not diagnostic. Blood sugar management requires a comprehensive approach including diet, exercise, and medical guidance.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-435786030113e7bd085186ec